Scaling Single-Cell Sequencing. Accelerating Cures.
Sansimeon is a biotechnology company pioneering a high-throughput, streamlined platform for scalable single-cell sequencing that can directly process complex clinical samples such as whole blood and bone marrow aspirates without compromising performance. The platform supports immune profiling via TCR repertoire analysis, genome-wide CRISPR screening, and personalized medicine applications. Technologies originated from research at Massachusetts General Hospital (Harvard Medical School). Applications include biomarker discovery, drug target identification, cell therapy development, and clinical trial optimization.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.
Create Free Account
